No formal drug interaction studies have been conducted with<unk> . Although it is advised that patients are not administered live virus vaccines (e.g. the oral polio vaccine) while undergoing treatment with<unk>  due to the compromised ability to fight the attenuated viruses seen in patients being treated with<unk> .
Ofatumumab
Daratumumab
Alirocumab
Lanadelumab
Acalabrutinib
Tralokinumab
Sacituzumab govitecan
Bezlotoxumab